查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1850408

手术影像市场按组件、技术、模式、移动性/安装类型、影像解析度/格式、临床用途和最终用户划分 - 全球预测 2025-2032

Surgical Imaging Market by Component, Technology, Modality, Mobility & Installation, Imaging Resolution & Format, Clinical Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，手术影像市场将成长至 102.4 亿美元，复合年增长率为 13.99%。

主要市场统计数据
基准年2024年 35.9亿美元
预计2025年 41亿美元
预测年份：2032年 102.4亿美元
复合年增长率（%） 13.99%

临床重点和技术进步的融合正在将外科影像转变为手术卓越性和手术弹性的策略性推动因素

外科影像融合了先进的视觉化技术、手术效率和以病人为中心的诊疗概念，重塑了临床医师的术中决策方式。现代外科手术环境越来越依赖高保真影像来减少术中不确定性，实现更精准的切除、更有针对性的介入并改善手术结果。随着数位化架构和微型成像技术的进步，外科团队正在采用整合式视觉化平台，将即时成像与导航、扩增实境迭加和精简的资料管理相结合。

如今，临床医生和医院领导层需要兼具临床清晰度和营运价值的解决方案。因此，供应商优先考虑可互通的架构和以使用者为中心的介面，以最大限度地减少急诊护理中的工作流程摩擦。这不仅带来了技术变革，也带来了组织变革。包括外科专家、放射科、生物医学工程和IT部门在内的多学科团队必须围绕影像处理主导流程的共用绩效指标和管治达成一致。这种转变有利于在影像品质、易用性以及与电子健康记录和手术全期资讯系统的无缝整合之间取得平衡的系统。

展望未来，我们预计製造商和医疗保健系统之间的合作将进一步加强，重点关注可重复的结果和基于证据的程序标准化。投资决策将取决于影像解决方案能否显着降低手术表现的差异性，同时透过培训、服务和分析来支持其应用。简而言之，手术成像正在从一种辅助工具发展成为实现卓越手术和营运韧性的策略推动者。

模态融合、软体定义功能和价值驱动的筹资策略正在推动外科影像领域发生重大结构性变化

过去几年，外科影像领域经历了一场变革性的转变，其范围已从设备的逐步升级延伸至医疗服务提供和组织方式的系统性变革。一项根本性的变化是从单一模态工具转向多模态生态系统，该生态系统融合了二维透视、断层合成、基于CT的三维重建以及基于MRI的术中引导。这种融合增强了空间理解，并支持在护理点进行复杂的决策。

随着各种成像模式的融合，基于软体的影像处理也应运而生。人工智慧和先进的影像处理演算法已成为增强对比度、降低杂讯和自动化常规测量的核心。因此，影像处理供应商不仅在硬体保真度方面竞争，还在软体功能方面竞争，以提高吞吐量和诊断信心。此外，无缝连接和标准化资料交换通讯协定正在促进影像处理实验室与医院基础设施的整合，从而实现术中工作流程同步和回顾性结果分析。

经济和监理力量也在重塑采购行为。医疗系统正在强调优先考虑总体拥有成本、保证运作、快速部署和可预测维护的服务模式。同时，临床相关人员要求提供临床效用和价值的证据，这些证据可以透过降低併发症发生率、缩短手术时间和改善功能结果来衡量。总而言之，这些变化迫使医疗服务提供者和供应商围绕协作、数据丰富的伙伴关係关係调整其策略，以加速先进外科影像技术的普及并扩大临床效益。

不断变化的关税压力如何重塑整个外科成像供应链的筹资策略、製造足迹和供应商选择

美国关税情势为采购、供应链规划和供应商选择带来了新的考量，影响了整个外科影像生态系统的设备定价和筹资策略。关税正在影响区域製造地的决策，导致一些供应商重新评估製造地和供应商合同，以减轻成本压力。为此，一些公司正在探索双重采购策略、近岸外包方案以及包含价格稳定条款和库存缓衝的长期供应商协议，以保持临床服务的连续性。

营运团队和采购部门越来越多地将关税因素纳入采购计划，评估采购现成库存和等待更优惠关税条款之间的利弊。因此，某些类别的影像设备的采购时间较长，资本规划週期通常包含应对进口关税波动的紧急准备金。这种趋势也促使供应商提供灵活的商业条款，例如价格保证和延期交货协议，以消除供应商的关税相关风险。

从策略角度来看，关税环境将加速供应商整合和本地合作模式。拥有成熟国内製造能力和强大本地服务网路的供应商将获得显着的竞争优势，能够更快地部署并降低生命週期物流成本，同时最大限度地降低跨境关税波动带来的风险。相关人员应预期，在受关税影响的环境中，企业将寻求在成本、通路和营运确定性之间取得平衡，因此短期内合约框架、物流策略和供应商实质审查实务将持续调整。

可操作的分割情报，将影像技术、临床应用和最终用户环境结合起来，以加速采用和临床整合

了解细分市场的动态对于使产品开发和上市策略与实际临床需求保持一致至关重要。将技术分为二维和3D成像，二维成像包括立体定位成像和断层合成成像，这些成像模式仍然适用于需要快速可视化和最小占用空间的大批量手术。相较之下，三维成像细分为基于CT的三维繫统和基于MRI的三维系统，后者专注于体积重建和软组织造影，用于复杂的手术规划和术中引导。

应用塑造了心血管、胃肠道、神经系统、整形外科和泌尿系统手术的临床提案主张。心血管手术优先考虑高时间分辨率和精确的血管可视化，以支持基于导管的手术；而消化器官系统和泌尿器官系统手术通常需要紧凑、灵活的成像系统，以便于内视镜检查。神经系统病例需要卓越的空间精确度和脑组织对比度，以指导切除手术并保留功能。整形外科注重骨骼细节和术中对位，以优化植入定位并最大限度地降低再次手术率。根据这些差异化的临床需求客製化产品功能，可以提高产品被采用的可能性并加强临床伙伴关係。

终端使用者细分透过将门诊手术中心、诊断中心和医院区分为不同的部署环境，进一步完善了部署策略。门诊手术中心包括独立中心和医院附属中心，这些中心优先考虑吞吐量和狭窄的手术范围。诊断中心包括癌症中心和诊断影像中心，其中术前规划、病变定位和切片检查指导是关键用例。医院分为私立和公立机构，以平衡更广泛的手术组合、复杂的病例组合和密集的采购流程。认识到这些差异，提供者和供应商可以将解决方案的外形规格、服务模式和定价结构与每种客户类型的业务现实和决策路径相匹配。

区域动态和基础设施差异将影响全球手术影像市场的采用路径、监管反应和商业机会

区域动态对外科影像生态系统的技术采用、监管途径和商业模式有重大影响。在美洲，医疗系统对能够展现手术互通性并支援捆绑支付模式的整合解决方案表现出强烈的需求，而北美医疗中心通常优先考虑互通性、临床证据和响应迅速的供应商支援网络。在该地区的部分地区，清晰的监管和成熟的报销途径有助于新型术中影像应用的早期临床应用。

由于法规差异和医疗基础设施的差异，欧洲、中东和非洲地区的采用模式也存在差异。西欧医疗机构在明确的医疗技术评估和临床指南的支持下，通常会迅速采用先进的影像技术。在中东和非洲部分地区，对三级医疗中心和转诊医院的投资正在推动人们对用于专科手术的高端影像处理平台的兴趣，但严重的系统级容量限制可能会减缓采用速度。

在亚太地区，快速的基础设施投资、不断扩张的私人医院网路以及对外科专科化的日益重视，为影像创新创造了肥沃的条件。拥有强大医疗设备生态系统的国家正在加速采用混合手术室和影像导引手术，而新兴市场则优先考虑紧凑、经济高效的解决方案，以满足有限的资本预算。此外，对于寻求优化成本结构和缩短供应链的供应商来说，亚太地区正成为重要的製造和研发中心，从而影响全球部署时间表和商业伙伴关係。

竞争格局分析揭示了平台模组化、软体差异化和服务卓越性如何推动供应商定位和伙伴关係

手术影像领域的竞争态势主要集中在老牌设备製造商、专业软体供应商以及专注于利基临床应用的新兴技术参与企业之间。现有的系统供应商持续投资模组化平台，这些平台可在多个手术室之间扩展功能，同时利用现有服务网路来确保执行时间和可预测的生命週期成本。同时，专业软体公司凭藉先进的影像处理、导航演算法和分析技术脱颖而出，从影像资料集中挖掘临床价值。

策略联盟、定向收购和共同开发伙伴关係是当前活动的特征，供应商正努力将无与伦比的硬体与软体智慧和临床工作流程专业知识相结合。这些联盟通常优先考虑与电子健康记录、云端基础分析和手术规划工具的集成，以提供无缝的端到端工作流程。此外，供应商正在尝试订阅和基于结果的合约模式，将供应商的报酬与临床表现挂钩，为供应商提供了另一种无需大量前期投资即可获得先进影像处理功能的途径。

卓越的服务仍是竞争优势。提供全面培训、反应迅速的现场服务和主动零件管理的供应商，能够确保更高的采用率和更高的生命週期价值。同时，那些带来颠覆性功能（例如基于人工智慧的组织表征或紧凑型术中磁振造影解决方案）的新参与企业，必须优先考虑严格的临床检验和实施后支持，以赢得外科团队和采购委员会的信任。

协调采购、互通性、商业化和临床医生采用以维持影像主导价值的实用策略建议

产业领导者应采取平衡近期业务重点与影像处理化医疗路径长期策略投资的方法。首先，透过定义与影像投资相关的可衡量绩效指标（例如降低再手术率和提高术中决策信心），使采购采购惯例与临床结果目标一致。将采购决策与明确的临床和财务指标挂钩，有助于合理化资本配置，并确保外科、放射科和财务相关人员的跨职能支援。

其次，在评估新系统时，优先考虑互通性和开放标准。支援标准化资料交换并与导航、电子记录和分析平台整合的架构可以减少实施阻力，并在数位架构发展过程中为您的投资提供面向未来的保障。第三，考虑灵活的商业模式，以降低关税和供应链风险。这包括区域维护协议、延长保固期和分阶段部​​署等选项，使您能够分散资本风险，同时提升临床能力。

第四，我们将透过结构化的培训计画、基于模拟的入职培训和多学科管理，投资于临床医生的采用，将影像技术纳入临床方案。有效的变革管理将推动管治，并最大限度地提高技术投资回报。最后，我们将与学术中心和科技公司建立创新伙伴关係，试点基于人工智慧的组织描绘和扩增实境迭加等先进应用。

透过整合临床医生访谈、临床文献综述和交叉检验的多方法研究途径获得基于证据的策略见解

本执行摘要所依据的研究结合了多种定性和定量方法，以确保获得稳健的多观点洞察。主要研究包括与不同类型和地区的医院的临床负责人、生物医学工程师、采购负责人和产品经理进行结构化访谈。这些访谈重点在于临床工作流程、采购标准以及术中影像实施的优先事项，从而提供有关营运限制和决策驱动因素的第一手观点。

二次研究包括对同行评审的临床研究、监管备案文件、产品手册和上市公司资讯揭露进行系统性回顾，以检验临床声明、技术能力和商业策略。分析框架整合了技术评估、应用映射和最终用户细分，以得出切实可行的见解。每个阶段的研究结果随后与专家进行交叉验证研讨会，以协调相互衝突的输入并检验假设的敏感性。

调查方法限制包括法规环境的区域差异和各机构报告标准的差异；这些问题已透过分层抽样和敏感性分析得到解决。在适当的情况下，我们清楚地记录了假设，并参考专家共识来解释模糊或专有数据。这种混合方法提供了一种平衡的、基于证据的视角，旨在为外科影像诊断相关人员提供营运决策和策略规划资讯。

综合证据和策略，展示如何透过协作实施基于影像处理的工作流程来持续改善病患治疗效果和业务绩效

外科影像技术正从一项辅助技术转变为现代外科医疗服务的核心组成部分，影响着临床结果、工作流程设计和供应商生态系统。多模态影像、先进软体和互联工作流程的融合，为减少手术差异、提高手术精准度以及实现数据主导的改进週期创造了机会。同时，关税趋势进一步加剧了采购和供应链的复杂性，因此务实的筹资策略和灵活的商业性安排至关重要。

积极主动地将临床目标与采购和供应商伙伴关係关係结合的组织，将获得最大的利益。注重互通性、严格的临床检验和全面的服务模式，将加速影像技术的采用，并将影像技术嵌入标准化的护理路径。同时，能够平衡硬体效能、软体智慧和可靠服务的供应商将保持竞争优势。

最终，取得进展的关键在于外科医生、放射科医生、生物医学团队和产业合作伙伴齐心协力，将影像处理技术实用化，并对患者照护和机构绩效产生可衡量的影响。透过优先考虑证据、互通性和以临床医生为中心的设计，相关人员可以克服当前的困境，并将外科影像技术作为临床差异化的可持续来源。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 推出结合机器人手术和先进多模态影像诊断的混合手术室
  • 新兴的微创萤光成像技术提高了肿瘤边缘的可视化
  • 将扩增实境覆盖整合到内视镜手术中，以提供即时解剖指导
  • 术中锥状射束CT 系统的进步可改善整形外科手术中的 3D 影像
  • 开发具有基于人工智慧的影像分析功能的可携式手持超音波设备，用于照护现场诊断
  • 使用机器学习演算法优化术中透视系统中的辐射剂量
  • 造影超音波技术在微创手术中检测肝臟肿瘤的商业化应用

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

8. 外科影像市场（按组件）

  • 配件和耗材
    • 造影剂和染料（ICG）
    • 窗帘和罩子
  • 硬体
    • 电缆和连接
    • 相机镜头和瞄准镜
    • 检测器和感测器
    • 显示和记录器
    • 影像系统
    • 光源
  • 服务
    • 安装和检验
    • 维护和维修
    • 託管服务
    • 培训和教育
  • 软体
    • 3D重建
    • 人工智慧应用
    • 剂量管理
    • 影像处理
    • 工作流程和 PACS 集成

9. 外科影像市场（按技术）

  • 二维成像
    • 立体定位成像
    • 断层合成
  • 3D成像
    • 基于CT的3D
    • 基于MR的3D

第 10 章。按模式分類的手术影像市场

  • 内视镜影像
  • 磁振造影
  • 光学和分子成像
    • NIR/ICG萤光
    • 光学同调断层扫描
  • 手术显微镜
  • 超音波
  • X射线和萤光透视
    • 固定C臂/血管造影术
      • 天花板安装系统
      • 混合手术室系统
    • 术中 CT/O 臂
    • 移动式C臂
      • 全尺寸C臂
      • 迷你C臂

第 11 章：手术影像市场流动性与安装

  • 固定的
    • 天花板式
    • 落地式
  • 移动的
    • 推车底座
  • 移动式龙门架/滑动磁铁

12. 外科成像市场（按影像解析度和格式）

  • 4K
  • 8K
  • 颜色
  • 双通道可见光/近红外线
  • HD 1080p
  • 单色

13. 外科影像市场（依临床应用）

  • 心血管系统
    • 血管内
    • 结构性心臟
  • 耳鼻喉科/头颈科
    • 鼻窦
    • 颅底
  • 一般外科
    • 冒号
    • 肝胆系统
  • 神经外科
    • 功能性/DBS
    • 肿瘤切除术
  • 整形外科和创伤
    • 骨折固定
    • 脊椎手术
  • 泌尿系统和妇科
    • 子宫切除术
    • 摄护腺

第 14 章。按最终用户分類的手术影像市场

  • 门诊手术中心
  • 医院
    • 学术医疗中心
    • 社区医院
  • 专科诊所及办公室实验室

第 15 章。按地区分類的手术影像市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第 16 章。按组别分類的手术影像市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 17 章。按国家/地区分類的手术影像市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十八章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • GE HealthCare Technologies Inc.
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • FUJIFILM Holdings Corporation
    • Olympus Corporation
    • Stryker Corporation
    • Mindray Medical International Limited
    • Shimadzu Corporation
    • Hologic, Inc.
Product Code: MRR-501246437219

The Surgical Imaging Market is projected to grow by USD 10.24 billion at a CAGR of 13.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.59 billion
Estimated Year [2025] USD 4.10 billion
Forecast Year [2032] USD 10.24 billion
CAGR (%) 13.99%

How converging clinical priorities and technological advances are transforming surgical imaging into a strategic enabler of procedural excellence and operational resilience

Surgical imaging is at the confluence of advanced visualization, procedural efficiency, and patient-centered care, reshaping how clinicians approach intraoperative decision-making. Modern operating environments increasingly rely on high-fidelity imaging to reduce uncertainty during procedures, enabling more precise resections, targeted interventions, and improved outcomes. As digital architectures and miniaturized imaging technologies advance, surgical teams are adopting integrated visualization platforms that combine real-time imaging with navigation, augmented reality overlays, and streamlined data management.

Clinicians and hospital leaders now seek solutions that deliver both clinical clarity and operational value. Consequently, vendors prioritize interoperable architectures and user-centered interfaces that minimize workflow friction in high-acuity settings. The resulting shift is not merely technological; it is organizational. Cross-disciplinary teams, including surgical specialties, radiology, biomedical engineering, and IT, must align around shared performance metrics and governance for imaging-driven procedures. This transformation favors systems that balance image quality, ease of use, and seamless integration with electronic health records and perioperative information systems.

Looking ahead, the emphasis on reproducible outcomes and evidence-based procedure standardization will drive deeper collaboration between manufacturers and health systems. Investment decisions will hinge on the ability of imaging solutions to demonstrably reduce variability in procedural performance while supporting adoption through training, service, and analytics capabilities. In short, surgical imaging is evolving from an ancillary tool to a strategic enabler of procedural excellence and operational resilience.

Major structural changes in surgical imaging driven by modality convergence, software-defined capabilities, and value-oriented procurement strategies

Over the past several years, the surgical imaging landscape has experienced transformative shifts that extend beyond incremental device upgrades to systemic changes in how care is delivered and organized. One fundamental shift is the migration from single-modality tools toward multi-modal ecosystems that combine 2D fluoroscopy, tomosynthesis, CT-derived three-dimensional reconstructions, and MR-based intraoperative guidance. This amalgamation enhances spatial understanding and supports complex decision-making at the point of care.

Parallel to modality convergence is the rise of software-defined imaging. Artificial intelligence and advanced image-processing algorithms now play a central role in enhancing contrast, reducing noise, and automating routine measurements. Consequently, imaging vendors compete not only on hardware fidelity but on software capabilities that improve throughput and diagnostic confidence. Additionally, seamless connectivity and standardized data exchange protocols have catalyzed integration between imaging suites and the broader hospital infrastructure, enabling synchronized intraoperative workflows and retrospective outcome analytics.

Economic and regulatory forces have also reshaped procurement behaviors. Health systems emphasize total cost of ownership, uptime guarantees, and service models that prioritize rapid deployment and predictable maintenance. Simultaneously, clinical stakeholders demand evidence of clinical utility and value-measured through reductions in complication rates, shorter procedure times, or improved functional outcomes. Taken together, these shifts compel providers and suppliers to reorient strategies around collaborative, data-rich partnerships that accelerate adoption and scale the clinical benefits of advanced surgical imaging.

How evolving tariff pressures are reshaping procurement strategies, manufacturing footprints, and vendor selection across surgical imaging supply chains

The tariff landscape in the United States has introduced additional considerations for procurement, supply-chain planning, and vendor selection, affecting device pricing and sourcing strategies across the surgical imaging ecosystem. Tariffs influence decisions around regional manufacturing footprints, with some suppliers reassessing production locations and supplier contracts to mitigate cost exposure. In response, several organizations are exploring dual-sourcing strategies, nearshoring options, and longer-term supplier contracts that include price stabilization clauses and inventory buffering to preserve continuity of clinical services.

Operational teams and purchasing departments increasingly incorporate tariff scenarios into procurement timelines, evaluating the trade-offs between acquiring immediately available inventory versus waiting for products that can be sourced under more favorable customs conditions. As a result, procurement windows have lengthened for certain classes of imaging equipment, and capital planning cycles now more frequently include contingency allowances for import duty variability. These dynamics also incentivize vendors to offer flexible commercial terms that transfer some tariff-related risk away from the provider, such as price protection guarantees or deferred delivery agreements.

From a strategic perspective, the tariff environment accelerates vendor consolidation and local partnership models. Suppliers with established domestic manufacturing or robust localized service networks gain distinct competitive advantages because they can minimize exposure to cross-border tariff volatility while offering faster deployment and lower lifecycle logistics costs. In the near term, stakeholders should anticipate ongoing adjustments to contractual frameworks, logistics strategies, and vendor due diligence practices as organizations seek to balance cost, access, and operational certainty in a tariff-influenced environment.

Actionable segmentation intelligence that aligns imaging technologies, clinical applications, and end-user environments to accelerate adoption and clinical integration

Understanding segmentation dynamics is critical to aligning product development and go-to-market strategies with real-world clinical needs. When technologies are parsed into two-dimensional imaging and three-dimensional imaging, the two-dimensional category includes stereotactic imaging and tomosynthesis modalities that continue to serve high-volume procedures where rapid visualization and minimal footprint are paramount. In contrast, three-dimensional imaging subdivides into CT-based 3D systems and MR-based 3D systems that emphasize volumetric reconstruction and soft-tissue contrast for complex surgical planning and intraoperative guidance.

Applications shape clinical value propositions across cardiovascular, gastrointestinal, neurological, orthopedic, and urological procedures. Cardiovascular interventions prioritize high temporal resolution and precise vessel visualization to support catheter-based therapies, while gastrointestinal and urological procedures often call for compact, flexible imaging that fits within endoscopy suites. Neurological use cases demand exceptional spatial accuracy and brain-tissue contrast for resection guidance and functional preservation. Orthopedic implementations focus on bone detail and intraoperative alignment to optimize implant positioning and minimize revision rates. Tailoring product features to these differentiated clinical requirements increases adoption likelihood and reinforces clinical partnership.

End-user segmentation further refines deployment strategies, distinguishing ambulatory surgical centers, diagnostic centers, and hospitals as distinct adoption environments. Ambulatory surgical centers encompass both freestanding centers and hospital-associated centers that emphasize throughput and narrow procedural scopes. Diagnostic centers include cancer centers and imaging centers where preoperative planning, lesion localization, and biopsy guidance are primary use cases. Hospitals split into private and public institutions that balance broader procedural portfolios, complex case mixes, and centralized procurement processes. Recognizing these distinctions enables providers and vendors to match solution form factors, service models, and pricing structures to the operational realities and decision-making pathways of each customer type.

Regional dynamics and infrastructure variance that determine adoption pathways, regulatory readiness, and commercial opportunity across global surgical imaging markets

Regional dynamics exert a strong influence on technology adoption, regulatory pathways, and commercial models within the surgical imaging ecosystem. In the Americas, health systems exhibit a strong appetite for integrated solutions that demonstrate procedural efficiency and support bundled payment models, with North American centers often prioritizing interoperability, clinical evidence, and rapid vendor support networks. Regulatory clarity and established reimbursement pathways in portions of the region facilitate earlier clinical introduction for novel intraoperative imaging applications, although procurement cycles can remain elongated due to multi-stakeholder approvals.

In Europe, the Middle East & Africa, regulatory diversity and heterogeneity in healthcare infrastructure lead to differentiated adoption patterns. Western European centers frequently adopt advanced imaging modalities quickly when supported by clear health-technology assessments and clinical guideline endorsements, while other parts of the region require solutions that emphasize cost-effectiveness and adaptable service models. In the Middle East and parts of Africa, investment in tertiary centers and referral hospitals drives interest in high-end imaging platforms for specialized procedures, but broader system-level capacity constraints can slow diffusion.

Across the Asia-Pacific region, rapid infrastructure investment, expanding private hospital networks, and increasing emphasis on surgical subspecialization create fertile conditions for imaging innovation. Countries with strong medical-device ecosystems show accelerated uptake of hybrid operating rooms and image-guided surgery suites, whereas emerging markets prioritize compact and cost-effective solutions that fit constrained capital budgets. Moreover, the Asia-Pacific region is becoming an important manufacturing and R&D base for vendors looking to optimize cost structures and shorten supply chains, which in turn impacts global deployment timelines and commercial partnerships.

Competitive landscape analysis revealing how platform modularity, software differentiation, and service excellence drive vendor positioning and partnerships

Competitive dynamics in surgical imaging center on a mix of established device manufacturers, specialized software vendors, and emerging technology entrants that focus on niche clinical applications. Established system providers continue to invest in modular platforms that allow providers to scale functionality across multiple operating rooms while leveraging existing service networks to ensure uptime and predictable lifecycle costs. At the same time, specialist software firms are differentiating through advanced image processing, navigation algorithms, and analytics that extract incremental clinical value from imaging datasets.

Strategic alliances, targeted acquisitions, and co-development partnerships characterize current activity as vendors seek to pair hardware excellence with software intelligence and clinical workflow expertise. These collaborations often prioritize integration with electronic medical records, cloud-based analytics, and surgical planning tools to deliver seamless end-to-end workflows. Additionally, suppliers are experimenting with subscription and outcome-based contracting models that align vendor compensation with clinical performance, offering providers alternative ways to access advanced imaging capabilities without large upfront capital expenditure.

Service excellence remains a competitive differentiator. Vendors that offer comprehensive training, rapid field service, and proactive parts management secure stronger adoption and higher lifetime value. Meanwhile, newer entrants that bring disruptive capabilities-such as AI-driven tissue characterization or compact intraoperative MR solutions-must prioritize rigorous clinical validation and post-deployment support to gain the trust of surgical teams and procurement committees.

Practical strategic recommendations designed to align procurement, interoperability, commercialization, and clinician adoption for sustained imaging-driven value

Industry leaders should adopt a deliberate approach that balances near-term operational priorities with longer-term strategic investments in imaging-enabled care pathways. First, align procurement practices with clinical outcome objectives by defining measurable performance indicators tied to imaging investments, such as reductions in reoperation rates or improvements in intraoperative decision confidence. Linking purchasing decisions to clear clinical and financial metrics helps justify capital allocation and supports cross-functional buy-in across surgical, radiology, and finance stakeholders.

Second, prioritize interoperability and open standards when evaluating new systems. Solutions that support standardized data exchange and integrate with navigation, electronic records, and analytics platforms reduce implementation friction and future-proof investments against evolving digital architectures. Third, consider flexible commercial models that mitigate tariff and supply-chain risks, including options for localized maintenance agreements, extended warranties, and phased deployments that spread capital exposure while delivering incremental clinical capability.

Fourth, invest in clinician adoption through structured training programs, simulation-based onboarding, and multidisciplinary governance that embeds imaging into clinical protocols. Effective change management accelerates utilization and maximizes return on technology investments. Finally, cultivate innovation partnerships with academic centers and technology firms to pilot advanced applications-such as AI-assisted tissue delineation or augmented-reality overlays-under controlled study conditions that generate evidence for scaled adoption.

A multi-method research approach that integrates clinician interviews, clinical literature review, and cross-validation to produce evidence-grounded strategic insights

The research underpinning this executive summary combined multiple qualitative and quantitative approaches to ensure robust, multi-perspective insights. Primary research included structured interviews with clinical leaders, biomedical engineers, procurement executives, and product managers across diverse hospital types and geographic regions. These conversations focused on clinical workflows, procurement criteria, and priorities for intraoperative imaging adoption, providing firsthand perspectives on operational constraints and decision drivers.

Secondary research involved systematic review of peer-reviewed clinical studies, regulatory filings, product brochures, and public company disclosures to validate clinical claims, technological capabilities, and commercial strategies. The analytical framework integrated technology assessment with application mapping and end-user segmentation to generate actionable insights. Across stages, findings were triangulated through cross-validation workshops with subject-matter experts to reconcile conflicting inputs and test hypothesis sensitivity.

Limitations include variation in regional regulatory environments and heterogeneity in reporting standards across institutions, which the methodology accounted for through stratified sampling and sensitivity analyses. Where appropriate, assumptions were explicitly documented and expert consensus was used to interpret ambiguous or proprietary data. This mixed-methods approach yields a balanced, evidence-grounded perspective designed to inform operational decisions and strategic planning for stakeholders in surgical imaging.

Synthesis of evidence and strategy showing how collaborative adoption of imaging-enabled workflows can sustainably improve patient outcomes and operational performance

Surgical imaging is transitioning from a supporting technology to a central component of modern surgical care delivery, with implications for clinical outcomes, workflow design, and supplier ecosystems. The convergence of multi-modal imaging, advanced software, and connected workflows creates opportunities to reduce procedural variability, enhance surgical precision, and enable data-driven improvement cycles. At the same time, procurement and supply-chain complexities-heightened by tariff dynamics-require pragmatic sourcing strategies and flexible commercial arrangements.

Organizations that proactively align clinical goals with procurement and vendor partnerships stand to realize the greatest benefit. Emphasizing interoperability, rigorous clinical validation, and comprehensive service models will accelerate adoption and embed imaging within standardized care pathways. Meanwhile, vendors that marry hardware performance with software intelligence and dependable service will maintain competitive advantage.

Ultimately, the path forward rests on collaboration: between surgeons, radiologists, biomedical teams, and industry partners to operationalize imaging capabilities in ways that measurably improve patient care and institutional performance. By prioritizing evidence, interoperability, and clinician-centered design, stakeholders can navigate current headwinds and harness surgical imaging as a durable source of clinical differentiation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of hybrid operating rooms combining robotic surgery with advanced multimodal imaging
  • 5.2. Emergence of minimally invasive fluorescence imaging techniques to improve tumor margin visualization
  • 5.3. Integration of augmented reality overlays in endoscopic procedures for real-time anatomical guidance
  • 5.4. Advancements in intraoperative cone beam CT systems for enhanced 3D imaging during orthopedic surgeries
  • 5.5. Development of portable handheld ultrasound devices with AI-driven image analysis for point-of-care diagnostics
  • 5.6. Use of machine learning algorithms to optimize radiation dosing in intraoperative fluoroscopy systems
  • 5.7. Commercialization of contrast-enhanced ultrasound techniques for liver tumor detection in minimally invasive surgeries

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Imaging Market, by Component

  • 8.1. Accessories & Consumables
    • 8.1.1. Contrast Agents & Dyes (ICG)
    • 8.1.2. Drapes & Covers
  • 8.2. Hardware
    • 8.2.1. Cables & Connectivity
    • 8.2.2. Camera Heads & Scopes
    • 8.2.3. Detectors & Sensors
    • 8.2.4. Displays & Recorders
    • 8.2.5. Imaging Systems
    • 8.2.6. Light Sources
  • 8.3. Services
    • 8.3.1. Installation & Validation
    • 8.3.2. Maintenance & Repair
    • 8.3.3. Managed Services
    • 8.3.4. Training & Education
  • 8.4. Software
    • 8.4.1. 3D Reconstruction
    • 8.4.2. AI Applications
    • 8.4.3. Dose Management
    • 8.4.4. Image Processing
    • 8.4.5. Workflow & PACS Integration

9. Surgical Imaging Market, by Technology

  • 9.1. 2D Imaging
    • 9.1.1. Stereotactic Imaging
    • 9.1.2. Tomosynthesis
  • 9.2. 3D Imaging
    • 9.2.1. Ct-Based 3D
    • 9.2.2. Mr-Based 3D

10. Surgical Imaging Market, by Modality

  • 10.1. Endoscopic Imaging
  • 10.2. Magnetic Resonance
  • 10.3. Optical & Molecular Imaging
    • 10.3.1. NIR/ICG Fluorescence
    • 10.3.2. Optical Coherence Tomography
  • 10.4. Surgical Microscopy
  • 10.5. Ultrasound
  • 10.6. X-Ray & Fluoroscopy
    • 10.6.1. Fixed C-Arm/Angiography
      • 10.6.1.1. Ceiling-Mounted System
      • 10.6.1.2. Hybrid OR System
    • 10.6.2. Intraoperative CT/O-Arm
    • 10.6.3. Mobile C-Arm
      • 10.6.3.1. Full-Size C-Arm
      • 10.6.3.2. Mini C-Arm

11. Surgical Imaging Market, by Mobility & Installation

  • 11.1. Fixed
    • 11.1.1. Ceiling-Mounted
    • 11.1.2. Floor-Mounted
  • 11.2. Mobile
    • 11.2.1. Cart-Based
  • 11.3. Movable Gantry/Sliding Magnet

12. Surgical Imaging Market, by Imaging Resolution & Format

  • 12.1. 4K
  • 12.2. 8K
  • 12.3. Color
  • 12.4. Dual-Channel Visible/NIR
  • 12.5. HD 1080p
  • 12.6. Monochrome

13. Surgical Imaging Market, by Clinical Application

  • 13.1. Cardiovascular
    • 13.1.1. Endovascular
    • 13.1.2. Structural Heart
  • 13.2. ENT/Head & Neck
    • 13.2.1. Sinus
    • 13.2.2. Skull Base
  • 13.3. General Surgery
    • 13.3.1. Colorectal
    • 13.3.2. Hepatobiliary
  • 13.4. Neurosurgery
    • 13.4.1. Functional/DBS
    • 13.4.2. Tumor Resection
  • 13.5. Orthopedic & Trauma
    • 13.5.1. Fracture Fixation
    • 13.5.2. Spine Surgery
  • 13.6. Urology & Gynecology
    • 13.6.1. Hysterectomy
    • 13.6.2. Prostate

14. Surgical Imaging Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Hospitals
    • 14.2.1. Academic Medical Centers
    • 14.2.2. Community Hospitals
  • 14.3. Specialty Clinics & Office-Based Labs

15. Surgical Imaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Surgical Imaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Surgical Imaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. GE HealthCare Technologies Inc.
    • 18.3.2. Siemens Healthineers AG
    • 18.3.3. Koninklijke Philips N.V.
    • 18.3.4. Canon Medical Systems Corporation
    • 18.3.5. FUJIFILM Holdings Corporation
    • 18.3.6. Olympus Corporation
    • 18.3.7. Stryker Corporation
    • 18.3.8. Mindray Medical International Limited
    • 18.3.9. Shimadzu Corporation
    • 18.3.10. Hologic, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SURGICAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL SURGICAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SURGICAL IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS SURGICAL IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SURGICAL IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. SURGICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. SURGICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOVABLE GANTRY/SLIDING MAGNET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 320. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOVABLE GANTRY/SLIDING MAGNET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 321. GLOBAL SUR